583 related articles for article (PubMed ID: 27509913)
1. Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.
Rutkowska AZ; Szybiak A; Serkies K; Rachoń D
Pol Arch Med Wewn; 2016 Aug; 126(7-8):562-70. PubMed ID: 27509913
[TBL] [Abstract][Full Text] [Related]
2. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
3. Impact of endocrine disrupting chemicals on onset and development of female reproductive disorders and hormone-related cancer.
Scsukova S; Rollerova E; Bujnakova Mlynarcikova A
Reprod Biol; 2016 Dec; 16(4):243-254. PubMed ID: 27692877
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.
Rachoń D
Rev Endocr Metab Disord; 2015 Dec; 16(4):359-64. PubMed ID: 26831296
[TBL] [Abstract][Full Text] [Related]
5. Impact of endocrine disruptor chemicals in gynaecology.
Caserta D; Maranghi L; Mantovani A; Marci R; Maranghi F; Moscarini M
Hum Reprod Update; 2008; 14(1):59-72. PubMed ID: 18070835
[TBL] [Abstract][Full Text] [Related]
6. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.
Santaliz Casiano A; Lee A; Teteh D; Madak Erdogan Z; Treviño L
Endocrinology; 2022 May; 163(5):. PubMed ID: 35325096
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disrupting chemicals and breast cancer cells.
Darbre PD
Adv Pharmacol; 2021; 92():485-520. PubMed ID: 34452695
[TBL] [Abstract][Full Text] [Related]
9. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
Fenton SE
Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811
[TBL] [Abstract][Full Text] [Related]
10. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.
Winz C; Zong WX; Suh N
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23506. PubMed ID: 37598318
[TBL] [Abstract][Full Text] [Related]
11. Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.
Eve L; Fervers B; Le Romancer M; Etienne-Selloum N
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266302
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
Giulivo M; Lopez de Alda M; Capri E; Barceló D
Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
[TBL] [Abstract][Full Text] [Related]
13. Experimental Approaches for Characterizing the Endocrine-Disrupting Effects of Environmental Chemicals in Fish.
Celino-Brady FT; Lerner DT; Seale AP
Front Endocrinol (Lausanne); 2020; 11():619361. PubMed ID: 33716955
[TBL] [Abstract][Full Text] [Related]
14. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
[TBL] [Abstract][Full Text] [Related]
15. Endocrine-active chemicals in mammary cancer causation and prevention.
Jenkins S; Betancourt AM; Wang J; Lamartiniere CA
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753
[TBL] [Abstract][Full Text] [Related]
16. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer.
Di Donato M; Cernera G; Giovannelli P; Galasso G; Bilancio A; Migliaccio A; Castoria G
Mol Cell Endocrinol; 2017 Dec; 457():35-42. PubMed ID: 28257827
[TBL] [Abstract][Full Text] [Related]
17. Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs).
Rutkowska A; Rachoń D; Milewicz A; Ruchała M; Bolanowski M; Jędrzejuk D; Bednarczuk T; Górska M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Zgliczyński W
Endokrynol Pol; 2015; 66(3):276-81. PubMed ID: 26136137
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
[TBL] [Abstract][Full Text] [Related]
19. Methodological issues in human studies of endocrine disrupting chemicals.
Lee DH; Jacobs DR
Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disruption: fact or urban legend?
Nohynek GJ; Borgert CJ; Dietrich D; Rozman KK
Toxicol Lett; 2013 Dec; 223(3):295-305. PubMed ID: 24177261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
